nortriptyline has been researched along with Smoking Cessation in 83 studies
Nortriptyline: A metabolite of AMITRIPTYLINE that is also used as an antidepressive agent. Nortriptyline is used in major depression, dysthymia, and atypical depressions.
nortriptyline : An organic tricyclic compound that is 10,11-dihydro-5H-dibenzo[a,d][7]annulene substituted by a 3-(methylamino)propylidene group at position 5. It is an active metabolite of amitriptyline.
Smoking Cessation: Discontinuing the habit of SMOKING.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Bupropion and nortriptyline seem to be more effective in smoking cessation among SLC6A4 high-activity variant carriers, probably by blocking the increased serotonin transporter activity, thereby increasing serotonin levels." | 9.16 | Genetic variants in the serotonin transporter influence the efficacy of bupropion and nortriptyline in smoking cessation. ( Postma, DS; Quaak, M; van Schayck, CP; van Schooten, FJ; Wagena, EJ, 2012) |
| "Nortriptyline and nicotine replacement therapy are both effective for smoking cessation but the effect of the combination is less than either alone and evidence is lacking that combination treatment is more effective than either alone." | 9.13 | Nortriptyline plus nicotine replacement versus placebo plus nicotine replacement for smoking cessation: pragmatic randomised controlled trial. ( Aveyard, P; Fillingham, S; Johnson, C; Murphy, M; Parsons, A, 2008) |
| "Treatment with CBT + bupropion resulted in a better 6-month rate of smoking cessation compared to CBT+nortriptyline or CBT + placebo." | 9.12 | A controlled trial of nortriptyline, sustained-release bupropion and placebo for smoking cessation: preliminary results. ( Cesari, DH; Chatkin, JM; Fam, CF; Fritscher, CC; Haggsträm, FM; Sussenbach-Vaz, E, 2006) |
| "Bupropion SR treatment is an efficacious aid to smoking cessation in patients with COPD." | 9.11 | Efficacy of bupropion and nortriptyline for smoking cessation among people at risk for or with chronic obstructive pulmonary disease. ( Huibers, MJ; Knipschild, PG; van Schayck, CP; Wagena, EJ; Wouters, EF, 2005) |
| "To add nortriptyline hydrochloride to a behavioral smoking cessation program to enhance cessation rates and reduce withdrawal symptoms." | 9.08 | A randomized trial of nortriptyline for smoking cessation. ( Fryer, GE; Keller, RT; Licari, PA; Lofaso, D; Prochazka, AV; Weaver, MJ, 1998) |
| "The limited use of nortriptyline for smoking cessation is likely due to concerns about its serious adverse effects." | 8.87 | Safety of nortriptyline at equivalent therapeutic doses for smoking cessation: a systematic review and meta-analysis. ( Chaiyakunapruk, N; Dhippayom, T; Jongchansittho, T, 2011) |
| "This article reviews the efficacy of nortriptyline for smoking cessation based on a meta-analysis of the Cochrane Library." | 8.82 | Nortriptyline for smoking cessation: a review. ( Hughes, JR; Lancaster, T; Stead, LF, 2005) |
| "The antidepressant nortriptyline is a second-line pharmacotherapy for smoking cessation." | 7.78 | Translating the smoking cessation properties of the antidepressant nortriptyline using reinforcing, discriminative and aversive stimulus effects of nicotine in rats. ( Shoaib, M; Wing, VC, 2012) |
| "The objective of this work was to develop a simple and inexpensive transdermal formulation containing Nortriptyline Hydrochloride (NTH) for smoking cessation support therapy." | 7.75 | Nortriptyline for smoking cessation: release and human skin diffusion from patches. ( Alós, M; Garrigues, TM; Kostka, KH; Lehr, CM; Melero, A; Schaefer, UF, 2009) |
| "In concurrence with clinical findings proposing alleviation of withdrawal states as a possible mechanism of bupropion and nortriptyline's smoking cessation action, both drugs were found to ameliorate somatic signs of nicotine withdrawal in rodents." | 7.74 | Examining the clinical efficacy of bupropion and nortriptyline as smoking cessation agents in a rodent model of nicotine withdrawal. ( Shoaib, M; Wing, VC, 2007) |
| "Multiple, controlled clinical trials support the efficacy of nortriptyline as a smoking cessation agent." | 7.74 | Therapeutic drug monitoring of nortriptyline in smoking cessation: a multistudy analysis. ( Delucchi, K; Gorecki, J; Hall, SM; Humfleet, GL; Mooney, ME; Muñoz, RF; Reus, VI, 2008) |
| "Treatment with varenicline for smoking cessation is cost-effective compared with nortriptyline and unaided cessation and even cost-saving compared with bupropion and NRT." | 7.74 | Cost-effectiveness of varenicline compared with bupropion, NRT, and nortriptyline for smoking cessation in the Netherlands. ( Hoogendoorn, M; Rutten-van Mölken, MP; Welsing, P, 2008) |
| "Nortriptyline combined with transdermal nicotine resulted in an increased cessation rate with little effect on withdrawal symptoms." | 6.71 | A randomized trial of nortriptyline combined with transdermal nicotine for smoking cessation. ( Fryer, GE; Kick, S; Miyoshi, T; Prochazka, AV; Steinbrunn, C, 2004) |
| "This study aimed to compare the efficacy and safety of Vernonia cinerea (VC) and nortriptyline for smoking cessation." | 5.69 | Efficacy and Safety of Vernonia cinerea for Smoking Cessation: An Open-Label Randomized Controlled Trial. ( Budkaew, J; Chumworathayi, B; Sorncha, N; Tuenthosarn, K, 2023) |
| "There is high-certainty evidence that bupropion can aid long-term smoking cessation." | 5.41 | Antidepressants for smoking cessation. ( Hajizadeh, A; Hartmann-Boyce, J; Howes, S; Klemperer, E; Lindson, N; Livingstone-Banks, J; Theodoulou, A, 2023) |
| "We included randomised controlled trials (RCTs), cluster-RCTs and factorial RCTs, which measured smoking cessation at six months or longer, recruited adults who smoked combustible cigarettes at enrolment (excluding pregnant people) and randomised them to approved pharmacotherapies and technologies used for smoking cessation worldwide (varenicline, cytisine, nortriptyline, bupropion, nicotine replacement therapy (NRT) and e-cigarettes) versus no pharmacological intervention, placebo (control) or another approved pharmacotherapy." | 5.41 | Pharmacological and electronic cigarette interventions for smoking cessation in adults: component network meta-analyses. ( Agrawal, S; Aveyard, P; Fanshawe, TR; Freeman, SC; Hajizadeh, A; Hartmann-Boyce, J; Lindson, N; Livingstone-Banks, J; Ordóñez-Mena, JM; Sutton, AJ; Theodoulou, A; Zhu, S, 2023) |
| "To evaluate the efficacy of nortriptyline (NOR) added to a multi-component smoking cessation intervention, which included cognitive-behavioural therapy (CBT) and provision of nicotine replacement therapy (NRT)." | 5.17 | A randomized controlled trial of a smoking cessation intervention conducted among prisoners. ( Archer, V; Butler, T; Indig, D; Richmond, R; Wilhelm, K; Wodak, A, 2013) |
| "A total of 255 participants, aged 30-70 years, received smoking cessation counselling and were assigned bupropion, nortriptyline or placebo randomly for 12 weeks." | 5.14 | The cost-effectiveness of antidepressants for smoking cessation in chronic obstructive pulmonary disease (COPD) patients. ( Kaper, J; Severens, JL; Van Schayck, CP; Wagena, EJ; Wouters, EF, 2009) |
| "Nortriptyline and nicotine replacement therapy are both effective for smoking cessation but the effect of the combination is less than either alone and evidence is lacking that combination treatment is more effective than either alone." | 5.13 | Nortriptyline plus nicotine replacement versus placebo plus nicotine replacement for smoking cessation: pragmatic randomised controlled trial. ( Aveyard, P; Fillingham, S; Johnson, C; Murphy, M; Parsons, A, 2008) |
| "The study design is a randomized controlled trial comparing confrontational counselling delivered by a respiratory nurse combined with nortriptyline for smoking cessation (experimental group), health education and promotion delivered by a respiratory nurse combined with nortriptyline for smoking cessation (control group 1), and "care as usual" delivered by the GP (control group 2)." | 5.12 | Efficacy of confrontational counselling for smoking cessation in smokers with previously undiagnosed mild to moderate airflow limitation: study protocol of a randomized controlled trial. ( Huibers, MJ; Kotz, D; van Schayck, OC; Wesseling, G, 2007) |
| "This study assessed the relationship between beliefs about drug assignment and abstinence status in two treatment studies using nortriptyline hydrochloride as an adjunct to smoking cessation." | 5.12 | Belief about drug assignment and abstinence in treatment of cigarette smoking using nortriptyline. ( Gorecki, JA; Hall, SM; Humfleet, GL; Muñoz, RF; Reus, VI, 2007) |
| "Treatment with CBT + bupropion resulted in a better 6-month rate of smoking cessation compared to CBT+nortriptyline or CBT + placebo." | 5.12 | A controlled trial of nortriptyline, sustained-release bupropion and placebo for smoking cessation: preliminary results. ( Cesari, DH; Chatkin, JM; Fam, CF; Fritscher, CC; Haggsträm, FM; Sussenbach-Vaz, E, 2006) |
| "Bupropion SR treatment is an efficacious aid to smoking cessation in patients with COPD." | 5.11 | Efficacy of bupropion and nortriptyline for smoking cessation among people at risk for or with chronic obstructive pulmonary disease. ( Huibers, MJ; Knipschild, PG; van Schayck, CP; Wagena, EJ; Wouters, EF, 2005) |
| "This study showed that nortriptyline significantly increases the smoking cessation rate in chronic smokers, as compared to the placebo group, without any significant side effects." | 5.10 | Stopping smoking: a prospective, randomized, double-blind study comparing nortriptyline to placebo. ( da Costa, CL; Lourenço, MT; Younes, RN, 2002) |
| "Nortriptyline is a promising adjunct for smoking cessation." | 5.08 | Nortriptyline and cognitive-behavioral therapy in the treatment of cigarette smoking. ( Frederick, S; Hall, SM; Hartz, DT; Humfleet, G; Muñoz, RF; Reus, VI; Sees, KL; Triffleman, E, 1998) |
| "To add nortriptyline hydrochloride to a behavioral smoking cessation program to enhance cessation rates and reduce withdrawal symptoms." | 5.08 | A randomized trial of nortriptyline for smoking cessation. ( Fryer, GE; Keller, RT; Licari, PA; Lofaso, D; Prochazka, AV; Weaver, MJ, 1998) |
| "There is high-certainty evidence that bupropion can aid long-term smoking cessation." | 5.05 | Antidepressants for smoking cessation. ( Hartmann-Boyce, J; Hong, B; Howes, S; Lindson, N; Livingstone-Banks, J, 2020) |
| "The primary objective of this review was to assess the effectiveness of interventions to increase adherence to medications for smoking cessation, such as NRT, bupropion, nortriptyline and varenicline (and combination regimens)." | 4.91 | Interventions to increase adherence to medications for tobacco dependence. ( Aveyard, P; Farley, A; Hollands, GJ; Lindson-Hawley, N; McDermott, MS; Vogt, F, 2015) |
| "The antidepressants bupropion and nortriptyline aid long-term smoking cessation." | 4.90 | Antidepressants for smoking cessation. ( Cahill, K; Hartmann-Boyce, J; Hughes, JR; Lancaster, T; Stead, LF, 2014) |
| "The limited use of nortriptyline for smoking cessation is likely due to concerns about its serious adverse effects." | 4.87 | Safety of nortriptyline at equivalent therapeutic doses for smoking cessation: a systematic review and meta-analysis. ( Chaiyakunapruk, N; Dhippayom, T; Jongchansittho, T, 2011) |
| " Medications addressed in this article include (1) first-line agents (nicotine replacement therapy, sustained-release bupropion) that have proven efficacy and are approved by the Food and Drug Administration (FDA) for smoking cessation, (2) second-line agents (nortriptyline, clonidine) that have proven efficacy but no FDA indication for smoking cessation, (3) approaches that use of combination or high-dose therapy, (4) herbal therapies, and (5) emerging therapies that are currently under investigation." | 4.83 | Pharmacologic interventions for smoking cessation. ( Corelli, RL; Hudmon, KS, 2006) |
| " There are now eight effective pharmacotherapies (nicotine gum, patch, nasal spray, inhaler, lozenge/tablet, bupropion, nortriptyline and clonidine) available to aid smoking cessation." | 4.83 | Developments in pharmacotherapy for tobacco dependence: past, present and future. ( Foulds, J; Steinberg, MB; Williams, JM; Ziedonis, DM, 2006) |
| " Nortriptyline and clonidine have demonstrated efficacy in aiding smoking cessation, but are regarded as second-line therapies." | 4.82 | Non-nicotine pharmacotherapies for smoking cessation. ( Juniper, Z; Lee, M; McRobbie, H, 2005) |
| "This article reviews the efficacy of nortriptyline for smoking cessation based on a meta-analysis of the Cochrane Library." | 4.82 | Nortriptyline for smoking cessation: a review. ( Hughes, JR; Lancaster, T; Stead, LF, 2005) |
| "This systematic review and meta-analysis shows that the use of nortriptyline for smoking cessation resulted in higher prolonged abstinence rates after at least 6 months compared to placebo treatment." | 4.82 | Should nortriptyline be used as a first-line aid to help smokers quit? Results from a systematic review and meta-analysis. ( Knipschild, P; Wagena, EJ; Zeegers, MP, 2005) |
| " There are now effective treatments for nicotine addiction and, in the UK, specialist services for the treatment of smoking cessation are becoming available in all areas." | 4.81 | Smoking cessation: integrating recent advances into clinical practice. ( Coleman, T, 2001) |
| " Smoking cessation is difficult due to nicotine addiction and withdrawal symptoms." | 3.76 | Current treatment options in smoking cessation. ( Bhat, A; Crain, D, 2010) |
| " There is strong evidence for the efficacy of the atypical antidepressant Bupropion as therapy for smoking cessation." | 3.75 | [Current and future medical drugs for smoking cessation]. ( Deissenrieder, F; Groneberg, D; Kusma, B; Mache, S; Quarcoo, D; Welte, T, 2009) |
| "Treatment with varenicline for smoking cessation is cost-effective compared with nortriptyline and unaided cessation and even cost-saving compared with bupropion and NRT." | 3.74 | Cost-effectiveness of varenicline compared with bupropion, NRT, and nortriptyline for smoking cessation in the Netherlands. ( Hoogendoorn, M; Rutten-van Mölken, MP; Welsing, P, 2008) |
| "In concurrence with clinical findings proposing alleviation of withdrawal states as a possible mechanism of bupropion and nortriptyline's smoking cessation action, both drugs were found to ameliorate somatic signs of nicotine withdrawal in rodents." | 3.74 | Examining the clinical efficacy of bupropion and nortriptyline as smoking cessation agents in a rodent model of nicotine withdrawal. ( Shoaib, M; Wing, VC, 2007) |
| "Nortriptyline combined with transdermal nicotine resulted in an increased cessation rate with little effect on withdrawal symptoms." | 2.71 | A randomized trial of nortriptyline combined with transdermal nicotine for smoking cessation. ( Fryer, GE; Kick, S; Miyoshi, T; Prochazka, AV; Steinbrunn, C, 2004) |
| "Pharmacological treatments for tobacco dependence, such as nicotine replacement therapy (NRT), have been shown to be safe and effective interventions for smoking cessation." | 2.61 | Interventions to increase adherence to medications for tobacco dependence. ( Aveyard, P; Farley, A; Hollands, GJ; Lindson, N; Naughton, F, 2019) |
| "Varenicline was superior to single forms of NRT (OR 1." | 2.49 | Pharmacological interventions for smoking cessation: an overview and network meta-analysis. ( Cahill, K; Lancaster, T; Perera, R; Stevens, S, 2013) |
| "Patients with COPD show higher nicotine dependence and seem to have greater difficulty in quitting smoking." | 2.47 | [Smoking in COPD]. ( Bernabé Barrios, MJ; Rodríguez Hermosa, JL; Santamaría Rodríguez, B; Zamarro García, C, 2011) |
| "Effective behavioral and pharmacologic treatments for smoking cessation are available." | 2.46 | Comparison of available treatments for tobacco addiction. ( Herman, AI; Sofuoglu, M, 2010) |
| "Nicotine dependence is a major health problem, with a large amount of smoking-related premature deaths and disabilities." | 2.46 | Pharmacogenetics of smoking cessation therapy. ( Bau, CH; Bizarro, L; Dobler, CJ; Kortmann, GL, 2010) |
| "Optimization of NRT is of importance in COPD patients because they may be more nicotine dependent and have more difficulties to quit than smokers without COPD." | 2.45 | Therapeutic strategies to optimize the efficacy of nicotine replacement therapies. ( Berlin, I, 2009) |
| "Individuals with mental illness are particularly disadvantaged by their use of tobacco, spending as much as 40% of their income on cigarettes." | 2.44 | Use of smoking cessation therapies in individuals with psychiatric illness : an update for prescribers. ( Campbell, LA; Kisely, S, 2008) |
| " Various dosage forms of nicotine replacement therapy increase smoking quit rates relative to placebo, but they generally do not result in 1-year quit rates of over 20%." | 2.41 | Effect of nonnicotine pharmacotherapy on smoking behavior. ( Golding, M; Hatsukami, DK; Jamerson, BD; Kotlyar, M, 2001) |
| "Rehabilitation of COPD-patients is an important part of the therapeutic management." | 1.33 | [COPD-rehabilitation]. ( Lichtenschopf, A; Zwick, H, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (6.02) | 18.2507 |
| 2000's | 48 (57.83) | 29.6817 |
| 2010's | 25 (30.12) | 24.3611 |
| 2020's | 5 (6.02) | 2.80 |
| Authors | Studies |
|---|---|
| Tuenthosarn, K | 1 |
| Budkaew, J | 1 |
| Sorncha, N | 1 |
| Chumworathayi, B | 1 |
| Hajizadeh, A | 2 |
| Howes, S | 2 |
| Theodoulou, A | 2 |
| Klemperer, E | 1 |
| Hartmann-Boyce, J | 5 |
| Livingstone-Banks, J | 4 |
| Lindson, N | 4 |
| Deng, X | 1 |
| Shang, X | 1 |
| Guo, K | 1 |
| Zhou, L | 1 |
| Wang, Y | 1 |
| Wu, Y | 1 |
| Liang, S | 1 |
| E, F | 1 |
| Liu, W | 1 |
| Wang, Z | 1 |
| Li, X | 1 |
| Yang, K | 1 |
| Ordóñez-Mena, JM | 1 |
| Fanshawe, TR | 2 |
| Sutton, AJ | 1 |
| Zhu, S | 1 |
| Aveyard, P | 4 |
| Freeman, SC | 1 |
| Agrawal, S | 1 |
| Hollands, GJ | 2 |
| Naughton, F | 1 |
| Farley, A | 2 |
| Hong, B | 2 |
| van Eerd, EAM | 1 |
| van Schayck, OCP | 1 |
| Wesseling, G | 3 |
| Kotz, D | 3 |
| Castaldelli-Maia, JM | 1 |
| Loreto, AR | 1 |
| Guimarães-Pereira, BBS | 1 |
| Carvalho, CFC | 1 |
| Gil, F | 1 |
| Frallonardo, FP | 1 |
| Ismael, F | 1 |
| Andrade, AG | 1 |
| Ventriglio, A | 1 |
| Richter, KP | 1 |
| Bhugra, D | 1 |
| Chiamulera, C | 1 |
| West, RJ | 1 |
| Akanbi, MO | 1 |
| Carroll, AJ | 1 |
| Achenbach, C | 1 |
| O'Dwyer, LC | 1 |
| Jordan, N | 1 |
| Hitsman, B | 1 |
| Bilaver, LA | 1 |
| McHugh, MC | 1 |
| Murphy, R | 1 |
| Wheat, H | 1 |
| Hall, S | 1 |
| Cahill, K | 2 |
| Stevens, S | 1 |
| Perera, R | 1 |
| Lancaster, T | 5 |
| Hughes, JR | 3 |
| Stead, LF | 4 |
| McDermott, MS | 1 |
| Lindson-Hawley, N | 1 |
| Vogt, F | 1 |
| Tosanguan, J | 1 |
| Chaiyakunapruk, N | 2 |
| Koilpillai, P | 1 |
| Wind, LA | 1 |
| Chavannes, NH | 2 |
| Kaper, J | 2 |
| Frijling, BD | 1 |
| van der Laan, JR | 1 |
| Wiersma, T | 1 |
| Goudswaard, AN | 1 |
| Carrozzi, L | 1 |
| Pistelli, F | 1 |
| Viegi, G | 1 |
| Huibers, MJ | 5 |
| van Schayck, OC | 2 |
| Bredesen, H | 1 |
| Lous, J | 1 |
| Kortmann, GL | 1 |
| Dobler, CJ | 1 |
| Bizarro, L | 1 |
| Bau, CH | 1 |
| Melero, A | 1 |
| Garrigues, TM | 1 |
| Alós, M | 1 |
| Kostka, KH | 1 |
| Lehr, CM | 1 |
| Schaefer, UF | 1 |
| Kusma, B | 1 |
| Mache, S | 1 |
| Deissenrieder, F | 1 |
| Quarcoo, D | 1 |
| Welte, T | 1 |
| Groneberg, D | 1 |
| Karanicolas, PJ | 1 |
| Montori, VM | 1 |
| Schünemann, HJ | 1 |
| Guyatt, GH | 1 |
| Berlin, I | 1 |
| Van Schayck, CP | 5 |
| Wagena, EJ | 6 |
| Wouters, EF | 2 |
| Severens, JL | 1 |
| Escobar-Chávez, JJ | 1 |
| Merino, V | 1 |
| Díez-Sales, O | 1 |
| Nácher-Alonso, A | 1 |
| Ganem-Quintanar, A | 1 |
| Herráez, M | 1 |
| Merino-Sanjuán, M | 1 |
| Crain, D | 1 |
| Bhat, A | 1 |
| Herman, AI | 1 |
| Sofuoglu, M | 1 |
| Allan, GM | 1 |
| Ivers, N | 1 |
| Els, C | 1 |
| Dhippayom, T | 1 |
| Jongchansittho, T | 1 |
| Prado, GF | 1 |
| Lombardi, EM | 1 |
| Bussacos, MA | 1 |
| Arrabal-Fernandes, FL | 1 |
| Terra-Filho, M | 1 |
| Santos, Ude P | 1 |
| Quaak, M | 1 |
| Postma, DS | 1 |
| van Schooten, FJ | 1 |
| Belcon, AL | 1 |
| Wing, VC | 2 |
| Shoaib, M | 2 |
| Richmond, R | 1 |
| Indig, D | 1 |
| Butler, T | 1 |
| Wilhelm, K | 1 |
| Archer, V | 1 |
| Wodak, A | 1 |
| Zamarro García, C | 1 |
| Bernabé Barrios, MJ | 1 |
| Santamaría Rodríguez, B | 1 |
| Rodríguez Hermosa, JL | 1 |
| DeGraff, AC | 1 |
| da Costa, CL | 1 |
| Younes, RN | 1 |
| Lourenço, MT | 1 |
| Arroll, B | 1 |
| Hall, SM | 6 |
| Humfleet, GL | 5 |
| Reus, VI | 6 |
| Muñoz, RF | 6 |
| Hartz, DT | 3 |
| Maude-Griffin, R | 1 |
| Jiménez-Ruiz, C | 1 |
| De Granda Orive, JI | 1 |
| Møller, AM | 1 |
| Tønnesen, H | 1 |
| Cullen, J | 1 |
| Prochazka, AV | 2 |
| Kick, S | 1 |
| Steinbrunn, C | 1 |
| Miyoshi, T | 1 |
| Fryer, GE | 2 |
| Knipschild, P | 1 |
| Zeegers, MP | 2 |
| Zwick, H | 1 |
| Lichtenschopf, A | 1 |
| Metcalfe, S | 2 |
| Moodie, P | 2 |
| McNee, W | 1 |
| McRobbie, H | 2 |
| Lee, M | 1 |
| Juniper, Z | 1 |
| Schroeder, SA | 1 |
| Knipschild, PG | 1 |
| Foulds, J | 1 |
| Steinberg, MB | 1 |
| Williams, JM | 1 |
| Ziedonis, DM | 1 |
| Haggsträm, FM | 1 |
| Chatkin, JM | 1 |
| Sussenbach-Vaz, E | 1 |
| Cesari, DH | 1 |
| Fam, CF | 1 |
| Fritscher, CC | 1 |
| Corelli, RL | 1 |
| Hudmon, KS | 1 |
| Hill, A | 1 |
| Duquet, N | 1 |
| Cofta-Woerpel, L | 1 |
| Wright, KL | 1 |
| Wetter, DW | 1 |
| Bullen, C | 1 |
| Whittaker, R | 1 |
| Fagerström, K | 1 |
| Frishman, WH | 1 |
| Gorecki, JA | 1 |
| Mooney, ME | 1 |
| Gorecki, J | 1 |
| Delucchi, K | 1 |
| Coffay, AO | 1 |
| Hoogendoorn, M | 1 |
| Welsing, P | 1 |
| Rutten-van Mölken, MP | 1 |
| Kisely, S | 1 |
| Campbell, LA | 1 |
| David, SP | 1 |
| Munafò, MR | 1 |
| Johnson, C | 1 |
| Fillingham, S | 1 |
| Parsons, A | 1 |
| Murphy, M | 1 |
| Benowitz, NL | 2 |
| Sees, KL | 1 |
| Humfleet, G | 1 |
| Frederick, S | 1 |
| Triffleman, E | 1 |
| Glassman, AH | 1 |
| Weaver, MJ | 1 |
| Keller, RT | 1 |
| Licari, PA | 1 |
| Lofaso, D | 1 |
| Gambassi, G | 1 |
| Bernabei, R | 1 |
| Tsoh, JY | 1 |
| Dempsey, DA | 1 |
| Goldenberg, RL | 1 |
| Dolan-Mullen, P | 1 |
| Ogburn, PL | 1 |
| Oncken, C | 1 |
| Orleans, CT | 1 |
| Slotkin, TA | 1 |
| Whiteside, HP | 1 |
| Yaffe, S | 1 |
| Coleman, T | 1 |
| Kotlyar, M | 1 |
| Golding, M | 1 |
| Hatsukami, DK | 1 |
| Jamerson, BD | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Helping People Adhere to Their Varenicline Treatment by Co-creating a Conversational Agent: A Feasibility Study[NCT05997901] | 40 participants (Anticipated) | Interventional | 2022-10-12 | Recruiting | |||
| "A Randomized Open-label, Superiority, Multicenter, Two-arm Intervention Study of the Effect of High-intensity vs. 'Low-intensity' Smoking Cessation Intervention in Active Smokers With COPD"[NCT04088942] | Phase 4 | 0 participants (Actual) | Interventional | 2023-07-01 | Withdrawn (stopped due to No funding) | ||
| [NCT02681848] | 180,000 participants (Anticipated) | Observational | 2006-09-01 | Active, not recruiting | |||
| Metabolism-informed Care for Smoking Cessation[NCT03227679] | 82 participants (Actual) | Interventional | 2016-05-18 | Completed | |||
| In-patient Smoking Cessation Intervention Using Counseling, Spirometry and Nicotine Replacement Therapy[NCT02470923] | 90 participants (Anticipated) | Interventional | 2015-08-31 | Recruiting | |||
| "Effectiveness of the Evaluation and Communication of Pulmonary Age as Help for Smoking Cessation: a Cluster Randomized Essay"[NCT04276116] | 800 participants (Anticipated) | Interventional | 2023-03-31 | Not yet recruiting | |||
| Assessing the Effectiveness of Peer-Facilitated Versus Self-Navigated Tobacco Cessation Interventions for Youths[NCT06053762] | 630 participants (Anticipated) | Interventional | 2023-10-01 | Not yet recruiting | |||
| Assessing the Effectiveness of Virtual Versus In-person Peer-motivation Smoking Cessation Interventions[NCT05181072] | 630 participants (Anticipated) | Interventional | 2022-01-05 | Recruiting | |||
| Nicotine Replacement Therapy in Nicotine-dependent Arrestees: a Monocentric Randomized Simple Blind Study[NCT02905734] | Phase 4 | 800 participants (Actual) | Interventional | 2017-01-03 | Completed | ||
| A Phase 2, Double-Blind, Randomized, Placebo-Controlled, Multicenter, Dose-Ranging Study of 100 or 250 μg of TA-NIC to Assess the Efficacy and Safety of the Vaccine as an Aid to Smoking Cessation[NCT00633321] | Phase 2 | 522 participants (Anticipated) | Interventional | 2007-05-31 | Completed | ||
| Targeting Orexin to Treat Nicotine Dependence[NCT03999099] | Phase 1 | 45 participants (Anticipated) | Interventional | 2019-09-26 | Recruiting | ||
| Human Laboratory Study of Varenicline and Bupropion for Nicotine Dependence[NCT00749658] | Phase 2/Phase 3 | 121 participants (Actual) | Interventional | 2008-11-30 | Completed | ||
| Combined Nortriptyline and Transdermal Nicotine for Smoking Cessation[NCT00018148] | Phase 2 | 158 participants (Actual) | Interventional | 1998-04-30 | Completed | ||
| An Innovative Digital Smoking Cessation Intervention for Low-Income Adults With Substance Use Disorder[NCT04419922] | 100 participants (Actual) | Observational | 2020-04-02 | Active, not recruiting | |||
| Tobacco Treatment Outreach to Reduce Disparities for Primary Care Populations[NCT01156610] | 706 participants (Actual) | Interventional | 2011-11-30 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
32 reviews available for nortriptyline and Smoking Cessation
| Article | Year |
|---|---|
Antidepressants for smoking cessation.
Topics: Adolescent; Adult; Antidepressive Agents; Bupropion; Child; Humans; Nicotinic Agonists; Nortriptylin | 2023 |
Efficacy and safety of antidepressants for smoking cessation: A systematic review and network meta-analysis.
Topics: Alcoholism; Antidepressive Agents; Bupropion; Humans; Network Meta-Analysis; Nortriptyline; Smoking; | 2023 |
Pharmacological and electronic cigarette interventions for smoking cessation in adults: component network meta-analyses.
Topics: Adult; Bupropion; Electronic Nicotine Delivery Systems; Female; Humans; Network Meta-Analysis; Nicot | 2023 |
Interventions to increase adherence to medications for tobacco dependence.
Topics: Benzazepines; Bupropion; Drug Therapy, Combination; Humans; Medication Adherence; Nicotinic Agonists | 2019 |
Antidepressants for smoking cessation.
Topics: Anti-Anxiety Agents; Antidepressive Agents; Bupropion; Humans; Nortriptyline; Randomized Controlled | 2020 |
The efficacy of smoking cessation interventions in low- and middle-income countries: a systematic review and meta-analysis.
Topics: Adult; Behavior Therapy; Bupropion; Cigarette Smoking; Clonidine; Counseling; Developing Countries; | 2019 |
Additional behavioural support as an adjunct to pharmacotherapy for smoking cessation.
Topics: Behavior Therapy; Bupropion; Combined Modality Therapy; Female; Humans; Nicotinic Agonists; Nortript | 2019 |
Pharmacological interventions for smoking cessation: an overview and network meta-analysis.
Topics: Adult; Alkaloids; Antidepressive Agents, Second-Generation; Azocines; Benzazepines; Bupropion; Human | 2013 |
Antidepressants for smoking cessation.
Topics: Anti-Anxiety Agents; Antidepressive Agents; Bupropion; Humans; Nortriptyline; Randomized Controlled | 2014 |
Interventions to increase adherence to medications for tobacco dependence.
Topics: Benzazepines; Bupropion; Drug Therapy, Combination; Humans; Medication Adherence; Nicotinic Agonists | 2015 |
Additional behavioural support as an adjunct to pharmacotherapy for smoking cessation.
Topics: Antidepressive Agents; Behavior Therapy; Benzazepines; Bupropion; Combined Modality Therapy; Counsel | 2015 |
Pharmacotherapy for smoking cessation.
Topics: Adrenergic Uptake Inhibitors; Antidepressive Agents, Tricyclic; Benzazepines; Bupropion; Humans; Nor | 2008 |
Pharmacogenetics of smoking cessation therapy.
Topics: Benzazepines; Bupropion; Clonidine; Genome-Wide Association Study; Humans; Nicotine; Nortriptyline; | 2010 |
Therapeutic strategies to optimize the efficacy of nicotine replacement therapies.
Topics: Administration, Cutaneous; Administration, Oral; Antidepressive Agents, Second-Generation; Antidepre | 2009 |
Comparison of available treatments for tobacco addiction.
Topics: Behavior Therapy; Benzazepines; Bupropion; Humans; Nicotine; Nortriptyline; Quinoxalines; Smoking Ce | 2010 |
Safety of nortriptyline at equivalent therapeutic doses for smoking cessation: a systematic review and meta-analysis.
Topics: Adrenergic Uptake Inhibitors; Antidepressive Agents, Tricyclic; Dose-Response Relationship, Drug; Hu | 2011 |
Behavioural interventions as adjuncts to pharmacotherapy for smoking cessation.
Topics: Antidepressive Agents; Behavior Therapy; Benzazepines; Bupropion; Combined Modality Therapy; Counsel | 2012 |
[Smoking in COPD].
Topics: Benzazepines; Bupropion; Clonidine; Comorbidity; Disease Progression; Europe; Humans; Motivation; Ni | 2011 |
Should nortriptyline be used as a first-line aid to help smokers quit? Results from a systematic review and meta-analysis.
Topics: Antidepressive Agents, Tricyclic; Humans; Nortriptyline; Smoking Cessation; Treatment Outcome | 2005 |
Non-nicotine pharmacotherapies for smoking cessation.
Topics: Adrenergic alpha-Agonists; Antidepressive Agents, Tricyclic; Bupropion; Clonidine; Dopamine Uptake I | 2005 |
Nortriptyline for smoking cessation: a review.
Topics: Antidepressive Agents, Tricyclic; Evidence-Based Medicine; Humans; Nortriptyline; Randomized Control | 2005 |
Developments in pharmacotherapy for tobacco dependence: past, present and future.
Topics: Adolescent; Adult; Bupropion; Clinical Trials as Topic; Clonidine; Drug Administration Routes; Femal | 2006 |
Pharmacologic interventions for smoking cessation.
Topics: Administration, Cutaneous; Administration, Inhalation; Antidepressive Agents, Second-Generation; Ben | 2006 |
A cost-effectiveness evaluation of single and combined smoking cessation interventions in Texas.
Topics: Adrenergic alpha-Agonists; Antidepressive Agents; Bupropion; Clonidine; Cost-Benefit Analysis; Decis | 2006 |
[Quit smoking is not just a matter or will].
Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Bupropion; Humans; Nicot | 2006 |
Smoking cessation 3: multicomponent interventions.
Topics: Behavior Therapy; Bupropion; Clonidine; Combined Modality Therapy; Humans; Motivation; Nicotine; Nor | 2007 |
A clinical imperative: assisting patients who smoke to reduce their risk of cardiovascular disease.
Topics: Benzazepines; Bupropion; Cardiovascular Diseases; Directive Counseling; Hospitalization; Humans; Neu | 2007 |
Smoking cessation pharmacotherapy--nicotine and non-nicotine preparations.
Topics: Administration, Cutaneous; Administration, Inhalation; Benzazepines; Bupropion; Chewing Gum; Clonidi | 2007 |
Use of smoking cessation therapies in individuals with psychiatric illness : an update for prescribers.
Topics: Antidepressive Agents, Second-Generation; Bupropion; Cognitive Behavioral Therapy; Dopamine Uptake I | 2008 |
[Bupropion: an effective new aid for smoking cessation].
Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Bupropion; Humans; Nortr | 2001 |
Smoking cessation: integrating recent advances into clinical practice.
Topics: Administration, Cutaneous; Antidepressive Agents; Bupropion; Ganglionic Stimulants; Health Education | 2001 |
Effect of nonnicotine pharmacotherapy on smoking behavior.
Topics: Amphetamines; Bupropion; Clonidine; Doxepin; Humans; Naltrexone; Nortriptyline; Selective Serotonin | 2001 |
18 trials available for nortriptyline and Smoking Cessation
| Article | Year |
|---|---|
Efficacy and Safety of Vernonia cinerea for Smoking Cessation: An Open-Label Randomized Controlled Trial.
Topics: Humans; Nortriptyline; Smoking; Smoking Cessation; Tobacco Smoking; Vernonia | 2023 |
Predictors of long-term smoking cessation in patients with COPD: results from a randomised controlled trial.
Topics: Aged; Female; Humans; Male; Middle Aged; Nortriptyline; Patient Participation; Prevalence; Pulmonary | 2017 |
Efficacy of confronting smokers with airflow limitation for smoking cessation.
Topics: Adrenergic Uptake Inhibitors; Adult; Aged; Counseling; Female; Humans; Logistic Models; Male; Middle | 2009 |
Efficacy of confronting smokers with airflow limitation for smoking cessation.
Topics: Adrenergic Uptake Inhibitors; Adult; Aged; Counseling; Female; Humans; Logistic Models; Male; Middle | 2009 |
Efficacy of confronting smokers with airflow limitation for smoking cessation.
Topics: Adrenergic Uptake Inhibitors; Adult; Aged; Counseling; Female; Humans; Logistic Models; Male; Middle | 2009 |
Efficacy of confronting smokers with airflow limitation for smoking cessation.
Topics: Adrenergic Uptake Inhibitors; Adult; Aged; Counseling; Female; Humans; Logistic Models; Male; Middle | 2009 |
The cost-effectiveness of antidepressants for smoking cessation in chronic obstructive pulmonary disease (COPD) patients.
Topics: Adult; Aged; Antidepressive Agents; Bupropion; Confidence Intervals; Cost-Benefit Analysis; Cotinine | 2009 |
Genetic variants in the serotonin transporter influence the efficacy of bupropion and nortriptyline in smoking cessation.
Topics: Alleles; Antidepressive Agents; Bupropion; Female; Genetic Variation; Genotype; Humans; Logistic Mod | 2012 |
A randomized controlled trial of a smoking cessation intervention conducted among prisoners.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Adult; Aged; Australia; Cognitive Behavioral Therapy; Foll | 2013 |
Pharmacologic therapy for nicotine addiction.
Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Bupropion; Double-Blind | 2002 |
Stopping smoking: a prospective, randomized, double-blind study comparing nortriptyline to placebo.
Topics: Adult; Antidepressive Agents, Tricyclic; Double-Blind Method; Humans; Logistic Models; Middle Aged; | 2002 |
Psychological intervention and antidepressant treatment in smoking cessation.
Topics: Adult; Antidepressive Agents; Behavior, Addictive; Bupropion; Cognitive Behavioral Therapy; Combined | 2002 |
Psychological intervention and antidepressant treatment in smoking cessation.
Topics: Adult; Antidepressive Agents; Behavior, Addictive; Bupropion; Cognitive Behavioral Therapy; Combined | 2002 |
Psychological intervention and antidepressant treatment in smoking cessation.
Topics: Adult; Antidepressive Agents; Behavior, Addictive; Bupropion; Cognitive Behavioral Therapy; Combined | 2002 |
Psychological intervention and antidepressant treatment in smoking cessation.
Topics: Adult; Antidepressive Agents; Behavior, Addictive; Bupropion; Cognitive Behavioral Therapy; Combined | 2002 |
Extended nortriptyline and psychological treatment for cigarette smoking.
Topics: Administration, Cutaneous; Adult; Antidepressive Agents, Tricyclic; Behavior Therapy; Combined Modal | 2004 |
A randomized trial of nortriptyline combined with transdermal nicotine for smoking cessation.
Topics: Administration, Cutaneous; Administration, Oral; Adolescent; Adult; Aged; Dose-Response Relationship | 2004 |
Efficacy of bupropion and nortriptyline for smoking cessation among people at risk for or with chronic obstructive pulmonary disease.
Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Bupropion; Depression; D | 2005 |
A controlled trial of nortriptyline, sustained-release bupropion and placebo for smoking cessation: preliminary results.
Topics: Adrenergic Uptake Inhibitors; Bupropion; Counseling; Delayed-Action Preparations; Double-Blind Metho | 2006 |
Belief about drug assignment and abstinence in treatment of cigarette smoking using nortriptyline.
Topics: Adult; Antidepressive Agents, Tricyclic; Behavior Therapy; Combined Modality Therapy; Dose-Response | 2007 |
Efficacy of confrontational counselling for smoking cessation in smokers with previously undiagnosed mild to moderate airflow limitation: study protocol of a randomized controlled trial.
Topics: Adrenergic Uptake Inhibitors; Combined Modality Therapy; Counseling; Humans; Nortriptyline; Patient | 2007 |
Nortriptyline plus nicotine replacement versus placebo plus nicotine replacement for smoking cessation: pragmatic randomised controlled trial.
Topics: Adolescent; Adult; Aged; Antidepressive Agents, Tricyclic; Behavior Therapy; Drug Therapy, Combinati | 2008 |
Nortriptyline and cognitive-behavioral therapy in the treatment of cigarette smoking.
Topics: Adult; Aged; Antidepressive Agents, Tricyclic; Cognitive Behavioral Therapy; Combined Modality Thera | 1998 |
A randomized trial of nortriptyline for smoking cessation.
Topics: Adrenergic Uptake Inhibitors; Adult; Aged; Antidepressive Agents, Tricyclic; Double-Blind Method; Fe | 1998 |
33 other studies available for nortriptyline and Smoking Cessation
| Article | Year |
|---|---|
Smoking cessation treatment outcomes among people with and without mental and substance use disorders: An observational real-world study.
Topics: Adult; Brazil; Bupropion; Cognitive Behavioral Therapy; Combined Modality Therapy; Comorbidity; Fema | 2018 |
What role does dopamine really play in tobacco addiction?
Topics: Antidepressive Agents, Tricyclic; Bupropion; Dopamine; Humans; Nortriptyline; Nucleus Accumbens; Smo | 2018 |
Commentary on Richmond et al. (2013): Cessation treatment for prisoners.
Topics: Adrenergic Uptake Inhibitors; Humans; Male; Nortriptyline; Smoking; Smoking Cessation | 2013 |
Cost-effectiveness analysis of clinical smoking cessation interventions in Thailand.
Topics: Adult; Combined Modality Therapy; Cost-Benefit Analysis; Counseling; Decision Trees; Female; Humans; | 2016 |
[Summary of the practice guideline 'Smoking cessation' from the Dutch College of General Practitioners].
Topics: Bupropion; Chronic Disease; Family Practice; Female; Humans; Male; Motivation; Netherlands; Nicotine | 2008 |
[Smoking cessation with special focus on primary health care].
Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Bupropion; Cardiovascula | 2009 |
Nortriptyline for smoking cessation: release and human skin diffusion from patches.
Topics: Administration, Cutaneous; Adrenergic Uptake Inhibitors; Chemistry, Pharmaceutical; Excipients; Fema | 2009 |
[Current and future medical drugs for smoking cessation].
Topics: Adrenergic alpha-Agonists; Antidepressive Agents; Behavior Therapy; Benzazepines; Bupropion; Cannabi | 2009 |
ACP Journal Club. "Pragmatic" clinical trials: from whose perspective?
Topics: Clinical Trials as Topic; Data Interpretation, Statistical; Humans; Insurance, Health, Reimbursement | 2009 |
Transdermal nortriptyline hydrocloride patch formulated within a chitosan matrix intended to be used for smoking cessation.
Topics: Adrenergic Uptake Inhibitors; Adult; Antidepressive Agents, Tricyclic; Chitosan; Female; Humans; Ion | 2011 |
Current treatment options in smoking cessation.
Topics: Adrenergic alpha-Agonists; Antidepressive Agents; Behavior Therapy; Benzazepines; Bupropion; Clonidi | 2010 |
Pharmacotherapy for smoking.
Topics: Benzazepines; Bupropion; Humans; Nicotinic Agonists; Nortriptyline; Quinoxalines; Smoking; Smoking C | 2011 |
A real-life study of the effectiveness of different pharmacological approaches to the treatment of smoking cessation: re-discussing the predictors of success.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Bupropion; Combined Modality Therapy; Female; Follow-Up | 2011 |
A real-life study of the effectiveness of different pharmacological approaches to the treatment of smoking cessation: re-discussing the predictors of success.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Bupropion; Combined Modality Therapy; Female; Follow-Up | 2011 |
A real-life study of the effectiveness of different pharmacological approaches to the treatment of smoking cessation: re-discussing the predictors of success.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Bupropion; Combined Modality Therapy; Female; Follow-Up | 2011 |
A real-life study of the effectiveness of different pharmacological approaches to the treatment of smoking cessation: re-discussing the predictors of success.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Bupropion; Combined Modality Therapy; Female; Follow-Up | 2011 |
Smoking cessation pharmacotherapy: a concise overview.
Topics: Adrenergic alpha-2 Receptor Agonists; Antidepressive Agents; Benzazepines; Bupropion; Clonidine; Hum | 2011 |
Translating the smoking cessation properties of the antidepressant nortriptyline using reinforcing, discriminative and aversive stimulus effects of nicotine in rats.
Topics: Animals; Antidepressive Agents; Avoidance Learning; Conditioning, Operant; Discrimination Learning; | 2012 |
A cheap medication for smoking cessation.
Topics: Antidepressive Agents, Tricyclic; Bupropion; Drug Administration Schedule; Humans; Nortriptyline; Sm | 2002 |
Success rates for nortriptyline.
Topics: Antidepressive Agents, Tricyclic; Bupropion; Humans; Nortriptyline; Smoking Cessation; Treatment Out | 2003 |
[Antidepressants for smoking cessation].
Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Bupropion; Evidence-Based Medicine; | 2004 |
[COPD-rehabilitation].
Topics: Acupuncture Therapy; Adrenergic alpha-Agonists; Antidepressive Agents, Second-Generation; Antidepres | 2005 |
PHARMAC and tobacco control in New Zealand: two licensed funded options are already available.
Topics: Administration, Cutaneous; Bupropion; Cost-Benefit Analysis; Drug Industry; Evidence-Based Medicine; | 2005 |
What to do with a patient who smokes.
Topics: Antidepressive Agents; Bupropion; Central Nervous System Stimulants; Clonidine; Counseling; Hotlines | 2005 |
What to do with a patient who smokes.
Topics: Antidepressive Agents; Bupropion; Central Nervous System Stimulants; Clonidine; Counseling; Hotlines | 2005 |
What to do with a patient who smokes.
Topics: Antidepressive Agents; Bupropion; Central Nervous System Stimulants; Clonidine; Counseling; Hotlines | 2005 |
What to do with a patient who smokes.
Topics: Antidepressive Agents; Bupropion; Central Nervous System Stimulants; Clonidine; Counseling; Hotlines | 2005 |
More on PHARMAC and tobacco control in New Zealand.
Topics: Bupropion; Cost-Benefit Analysis; Government Regulation; Humans; New Zealand; Nortriptyline; Smoking | 2006 |
Therapeutic drug monitoring of nortriptyline in smoking cessation: a multistudy analysis.
Topics: Adult; Data Interpretation, Statistical; Dose-Response Relationship, Drug; Drug Monitoring; Female; | 2008 |
Examining the clinical efficacy of bupropion and nortriptyline as smoking cessation agents in a rodent model of nicotine withdrawal.
Topics: Animals; Antidepressive Agents; Bupropion; Disease Models, Animal; Dose-Response Relationship, Drug; | 2007 |
Smoking cessation: tactics that make a big difference.
Topics: Adult; Benzazepines; Bupropion; Evidence-Based Medicine; Family Practice; Female; Humans; Nortriptyl | 2007 |
Cost-effectiveness of varenicline compared with bupropion, NRT, and nortriptyline for smoking cessation in the Netherlands.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Benzazepines; Bupropion; Cost-Benefit Analysis; Female; | 2008 |
Smoking cessation in primary care.
Topics: Drug Therapy, Combination; Evidence-Based Medicine; Humans; Nicotine; Nortriptyline; Primary Health | 2008 |
Treating tobacco addiction--nicotine or no nicotine?
Topics: Antidepressive Agents; Bupropion; Humans; Nicotine; Nortriptyline; Smoking Cessation; Substance With | 1997 |
Psychiatry and cigarettes.
Topics: Antidepressive Agents, Tricyclic; Cognitive Behavioral Therapy; Combined Modality Therapy; Depressiv | 1998 |
Antidepressants and smoking cessation.
Topics: Adrenergic Uptake Inhibitors; Affect; Animals; Antidepressive Agents, Tricyclic; Appetite; Humans; N | 1999 |
Development of major depression after treatment for smoking cessation.
Topics: Adult; Central Nervous System Stimulants; Chewing Gum; Combined Modality Therapy; Comorbidity; Depre | 2000 |
The use of pharmacotherapies for smoking cessation during pregnancy.
Topics: Antidepressive Agents; Bupropion; Education; Female; Health Promotion; Humans; Nortriptyline; Pregna | 2000 |
Antidepressants in the treatment of patients with COPD: possible associations between smoking cigarettes, COPD and depression.
Topics: Antidepressive Agents; Bupropion; Depressive Disorder; Humans; Lung Diseases, Obstructive; Nortripty | 2001 |